Shandong Buchang Pharmaceuticals Co., Ltd. (SHSE: 603858)
Health Care · Pharmaceuticals · CN
CN¥14.64
+0.83% today · -19.8% 1Y
Shandong Buchang Pharmaceuticals Co., Ltd. (SHSE: 603858) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.27B and employs 7,237 people.
Over the last twelve months the share price has lost 19.8%, trading between 14.01 and 18.47.
Tweenvest scores Shandong Buchang Pharmaceuticals Co., Ltd. across four factors: quality 70/100, value 38/100, growth 0/100, dividend 100/100. Its strongest factor is dividend.
603858 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.27B
- Revenue (TTM)
- $1.65B
- P/E
- 65.36
- EPS
- 0.22
- Dividend yield
- 3.89%
- Beta (5Y)
- 0.29
- 52-week high
- CN¥18.47
- 52-week low
- CN¥14.01
- Avg volume (3M)
- —
- Shares outstanding
- 1.04B
- Employees
- 7,237
- Next earnings
- —
About Shandong Buchang Pharmaceuticals Co., Ltd.
Shandong Buchang Pharmaceuticals Co., Ltd. is actively involved in China's pharmaceutical sector, specializing in the innovation, production, and distribution of medicinal products. The company provides a diverse range of treatments addressing various health conditions, including cardiovascular, cerebrovascular, urinary, digestive, and respiratory disorders, alongside gynecological problems and diabetes. Founded in 1993, this enterprise maintains its headquarters in Heze, China. Notably, it once operated as a subsidiary of Shanghai Zhangjiang (Group) Co., Ltd.
- ISIN
- CNE100002FV6
- Founded
- 1993
- Listed since
- Nov 18, 2016
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aether Industries LimitedNSEI: AETHER | $2.30B | Rs1,670.00 | -5.49% |
| Bausch Health Companies Inc.NYSE: BHC | $2.30B | $6.15 | +2.16% |
| Tonghua Dongbao Pharmaceutical Co., Ltd.SHSE: 600867 | $2.29B | CN¥7.86 | +1.68% |
| Harmony Biosciences Holdings, Inc.NasdaqGM: HRMY | $2.29B | $39.34 | -0.05% |
| Prestige Consumer Healthcare Inc.NYSE: PBH | $2.25B | $47.57 | +2.43% |
| Haw Par Corporation LimitedSGX: H02 | $2.25B | S$13.00 | -0.61% |
| ApicHope Pharmaceutical Group Co., Ltd.SZSE: 300723 | $2.22B | CN¥33.27 | +0.21% |
| Pharvaris N.V.NasdaqGS: PHVS | $2.19B | $31.68 | +1.57% |
Figures last refreshed Oct 4, 2026.